VECT-HORUS: Funding, Investors & Team (Sep 2026)
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and tumors. The vectors target receptors involved in “Receptor-Mediated Transport” (RMT, a physiological system for the transport into cells of endogenous substances by combining drugs or imaging agents to its vectors, VECT-HORUS allows them to cross biological barriers that restrict access to their target, notably the blood-brain barrier (BBB). Founded in 2005 by Alexandre Tokay and Dr. Michel Khrestchatisky, the biotech company is based in Marseille, Marseille, Provence-Alpes-Cote d'Azur.
VECT-HORUS has raised $5.3M across 1 funding round on record, the most recent an undisclosed round of $5.3M announced in Dec 2020.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
VECT-HORUS Company Profile and Key Stats
Latest funding round on record: Dec 2020.
VECT-HORUS Funding Rounds
VECT-HORUS Founders and Leadership Team
Contact details for the VECT-HORUS team: 1 of 1 has an email address on file.
Start 14-day free trial →VECT-HORUS Funding Compared to Other Biotechnology Startups
VECT-HORUS' latest round of $5.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VECT-HORUS in Biotechnology and Marseille
Companies Similar to VECT-HORUS
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
VECT-HORUS Funding FAQs
What does VECT-HORUS do?
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and tumors. The vectors target receptors involved in “Receptor-Mediated Transport” (RMT, a physiological system for the transport into cells of endogenous substances by combining drugs or imaging agents to its vectors, VECT-HORUS allows them to cross biological barriers that restrict access to their target, notably the blood-brain barrier (BBB). Founded in 2005 by Alexandre Tokay and Dr. Michel Khrestchatisky, the biotech company is based in Marseille, Marseille, Provence-Alpes-Cote d'Azur.
How much funding has VECT-HORUS raised?
VECT-HORUS has raised $5.3M across 1 round on record. The most recent is an undisclosed round of $5.3M announced in Dec 2020.
When did VECT-HORUS last raise funding?
VECT-HORUS' most recent funding round on record is an undisclosed round of $5.3M, announced in Dec 2020.
Who is the CEO of VECT-HORUS?
Alexandre Tokay is listed as CEO at VECT-HORUS.
Where is VECT-HORUS headquartered?
VECT-HORUS is based in Marseille, Provence-Alpes-Cote D'azur, France.
How many employees does VECT-HORUS have?
VECT-HORUS is in the 11-50 employee band.
How does VECT-HORUS' funding compare to other Biotechnology startups?
VECT-HORUS' latest round of $5.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's VECT-HORUS Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VECT-HORUS is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.